Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Wrigley

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|January 21, 1978
Osteonecrosis after intensive chemotherapy for Hodgkin's diseaseA R Timothy, A K Tucker, J S Malpas, et al.
British Journal of Cancer|October 1, 1994
Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II studyM T Seymour, P W Johnson, M R Hall, et al.
British Journal of Cancer|April 1, 1984
Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological studyM S Dorreen, J A Habeshaw, A G Stansfeld, et al.
Cancer|September 15, 1984
Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycinV J Harvey, M L Slevin, B A Ponder, et al.
Hematological Oncology|April 1, 1986
Second primary malignant neoplasms in patients treated for Hodgkin's disease at St Bartholomew's HospitalM S Dorreen, W M Gregory, P F Wrigley, et al.
Lancet (London, England)|December 20, 1975
Letter: Survival in acute myeloid leukaemiaS A Johnson, M E Beard, T A Lister, et al.
British Medical Journal|May 13, 1978
Radiotherapy in the treatment of Hodgkin's diseaseA R Timothy, S B Sutcliffe, A G Stansfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1980
The management of stage IIIA Hodgkin's diseaseA R Timothy, S B Sutcliffe, T A Lister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusionV J Harvey, M L Slevin, G W Aherne, et al.
British Medical Journal|October 25, 1975
Haemoglobin Rahere (beta Lys-Thr): A new high affinity haemoglobin associated with decreased 2, 3-diphosphoglycerate binding and relative polycythaemiaP A Lorkin, A D Stephens, M E Beard, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|January 21, 1978
Osteonecrosis after intensive chemotherapy for Hodgkin's diseaseA R Timothy, A K Tucker, J S Malpas, et al.
British Journal of Cancer|October 1, 1994
Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II studyM T Seymour, P W Johnson, M R Hall, et al.
British Journal of Cancer|April 1, 1984
Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological studyM S Dorreen, J A Habeshaw, A G Stansfeld, et al.
Cancer|September 15, 1984
Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycinV J Harvey, M L Slevin, B A Ponder, et al.
Hematological Oncology|April 1, 1986
Second primary malignant neoplasms in patients treated for Hodgkin's disease at St Bartholomew's HospitalM S Dorreen, W M Gregory, P F Wrigley, et al.
Lancet (London, England)|December 20, 1975
Letter: Survival in acute myeloid leukaemiaS A Johnson, M E Beard, T A Lister, et al.
British Medical Journal|May 13, 1978
Radiotherapy in the treatment of Hodgkin's diseaseA R Timothy, S B Sutcliffe, A G Stansfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1980
The management of stage IIIA Hodgkin's diseaseA R Timothy, S B Sutcliffe, T A Lister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusionV J Harvey, M L Slevin, G W Aherne, et al.
British Medical Journal|October 25, 1975
Haemoglobin Rahere (beta Lys-Thr): A new high affinity haemoglobin associated with decreased 2, 3-diphosphoglycerate binding and relative polycythaemiaP A Lorkin, A D Stephens, M E Beard, et al.
Pageof 10